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LETTERS TO THE EDITOR 
To the Editor: 
It is pleasant to note that Kondo and Adachi 
[1] are continuing their fine efforts [2] in the in-
vestigation of phosphofructokinase (PFK) as a 
control enzyme in epidermal glycolysis. The 
authors could have presented a more definitive 
discussion of the merits of assigning the major 
control function to PFK rather than, for example, 
to hexokinase (HK). This topic was discussed 
briefly elsewhere [3 ], but perhaps the readers of 
this Journal may appreciate additional comment. 
There are several reasons for examining PFK 
as a control enzyme in glucose utilization, and the 
authors have noted some of these. An important 
philosophical point is worth pursuing. Thus, for a 
nutrient such as glucose which undergoes several 
metabolic fates, one may ask the question: Where 
should control not be exerted? Two obvious an-
swers occur: At the beginning of the utilization 
sequence, before the metabolite branches into its 
several pathways; and at the end. Control at end-
product steps would cause disruptive accumula-
tion of intermediates during intervals of restric-
tion. Exclusive control at the first step would im-
pose simultaneous restraint over all the pathways 
traversed by the metabolite, and would not allow 
the cell to adjust the relative contribution of each 
pathway to satisfy changing metabolic needs. The 
alternate question, where should control be ex-
erted in a metabolic sequence, may also be con-
sidered. A plausible answer is, at the first com-
mitted step; that is, at a step (usually irrevers-
ible) beyond which most of the metabolite under-
goes only one fate . The first committed step in 
glycolysis is the reaction catalyzed by PFK. 
Since the branch point of glucose utilization is 
at glucose-6-phosphate (G6P), the enzyme cat-
alyzing conversion of glucose to G6P (i.e., hexo-
kinase) would not be considered a likely prospect 
for ultimate control of glycolysis. In fact, HK 
probably provides auxiliary control in response to 
the kinetic state of PFK. If, as is true for HK in 
other tissues, the epidermal enzyme is subject 
to product inhibition; then control of PFK will 
exert a similar effect on HK via the reciprocal 
effect of PFK activity on levels of hexose phos-
phates. Thus, inhibition of PFK will cause ac-
cumulation of fructose-6-phosphate and G6P, and 
consequent product inhibition of HK. It should 
be noted that if PFK turnoff is accompanied by 
activation of another G6P pathway (e.g., glycogen 
synthesis), the HK effect will be overcome by the 
ability of the accelerated route to maintain a low 
G6P level. Hence, the unique location of PFK in 
the glycolytic sequence provides an exquisite 
level of control, permitting the shunting of glu-
cose to alternate pathways without compromising 
the cell's ability to utilize the hexose; and yet re-
taining the capability of reducing overall glucose 
consumption. 
It may thus be seen that logic alone suggests 
that a major control point of glycolysis in all 
tissues must be the PFK step. The elegant stud-
ies of Kondo and Adachi in establishing a ''cross-
over point" at PFK during increased epidermal 
glycolysis [2 ], and in demonstrating multiple 
control of inhibition and activation of the en-
zyme [1 ], provide conclusive evidence of the 
validity of this theoretical conclusion. Halprin 
and Ohkawara [4] studied the properties of HK 
in epidermal hemogenates but were unable to 
assess the effect of G6P. It would now be worth-
while to examine purified epidermal HK and de-
termine whether it is subject to product in-
hibition. 
One aspect of the report by Kondo and Adachi 
[1] requires elaboration. The authors attributed 
the Pasteur effect (increased glycolysis in the 
absence of oxygen) to decreased ATP concen-
tration, which released PFK from inhibition. This 
mechanism is consistent with their observations 
[2] that ATP levels in monkey epidermis and 
appendages decreased to about one-half the con-
trol values during anoxia, in vitro. Such may not 
be the case in the live animal, however. For 
example Harkonen and Hopsu-Havu [5] ob-
served that the ATP concentration of human 
epidermis in vivo was essentially unchanged dur-
ing anoxia caused by suction blister formation, 
whe~eas lactate increased in approximate pro-
portiOn to glycogen decrease . As noted else-
where [6 ], this suggests that epidermis derives 
~uch of its energy needs from anaerobic glycoly-
Sis; and a factor other than ATP must be im-
plicated for release of PFK inhibition. Kondo and 
Adachi recognized that this role may be served 
by citrate, a Krebs cycle intermediate whose syn-
thesis is obviously compromised by lack of oxy-
gen. Reduced citrate concentration would re-
lease. PFK from inhibition, thereby allowing 
the mcreased glycolytic rate required to main-
tain epidermal ATP levels. 
The preceding discussion demonstrates that 
in vitro results must be interpreted with caution, 
and emphasizes the critical need for definitive in 
vivo studies of glycolytic control in epidermis. 
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This letter was submitted to Drs. Kondo and 
Adachi who offer the following reply: 
The meticulous work by Lowry et al [1 ], which 
measured all phosphorylated intermediates 
after acute ischemia, indicated that there are 
three regulatory steps in the brain: hexokinase, 
phosphorylase, and phosphofructokinase. The 
major purpose of our studies on PFK in skin was 
limited to presenting evidence that PFK in skin 
is one of the regulatory enzymes in glycolysis. 
We do not yet have sufficient experimental data 
to show directly whether hexokinase or phos-
phorylase rather than PFK are the key regulatory 
enzymes in the glycolytic pathway in skin. The 
suggestion by Drs. Johnson and Fusaro that 
skin hexokinase is controlled by PFK (directly 
or by G6P) is quite conceivable. We agree with 
their opinion that hexokinase must be purified 
for detailed kinetic studies. We did not discuss 
the G6P inhibition on hexokinase because of a 
lack of adequate information at the present time. 
As for the work of Harkonen and Hopsu-
Havu referred to by Drs. Johnson and Fusaro, we 
wonder whether there is any point of compari-
son between their work and ours. They mea-
sured the ATP level after "prolonged suction" 
(the first experimental point being after one hour), 
during which time many different regulatory 
mechanisms would have intervened. Our mea-
surements, on the other hand, were done within 
seconds and minutes. Obviously to study the 
primary action of an acute control mechanism, the 
primary changes which occur within seconds must 
be measured immediately. In addition, they did 
not measure the levels of phosphorylated sugars 
nor the oxygen concentration of the blister fluid; 
thus their experimental data neither conflict 
with ours nor explain an acute control mech-
anism. At present, we simply submit the possi-
bilities that either ATP or citrate or the combi-
nation of both affect PFK activity. We do not 
have sufficient data to establish a hierarchy 
among ATP, citrate, and other end-products. 
We agree with Drs. Johnson and Fusaro that 
there is a need for definitive in vivo studies of 
glycolytic control in the epidermis. On the other 
hand, we realize that such definitive in vivo 
studies on acute control mechanisms are ex-
tremely difficult to conduct. To explore any 
"mechanism," we have to rely on certain model 
systems. In our studies, we believe that sufficient 
evidence exists to indicate the potential of skin 
PFK to act as an efficient (allosteric) regulator 
of glycolysis. 
At any rate, studies on the regulatory mech-
anisms in the metabolism of skin have been ex-
tremely limited. We look forward to new de-
velopments and knowledge in this field. 
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Dear Sir: 
The paper entitled "Effects of Long Ultra-
violet Rays on Human Skin: Photoprotective or 
Photoaugmentative?" by Willis, Kligman, and 
Epstein in volume 59, page 416, December 1972, 
contains some valuable data and perhaps heralds 
a resurgence of interest in the effects of long 
wavelength ultraviolet on human skin. 
However, some explanation of what appears to 
be selective literature citing is required. Van 
der Leun and Stoop [1] are quoted as demon-
strating photorecovery of ultraviolet erythema 
when artificial erythemic radiation is followed by 
filtered sunlight exposure. Willis, Kligman, and 
Epstein deny this in passing in their discussion 
with no experimental data. More importantly, 
they disregard the finding of Van der Leun and 
Stoop that when 300 nm radiation is used as 
erythema producing radiation, preceded by ex-
posure to filtered sunlight, the erythema thresh-
old is reduced by a factor of 1.4. 
It is difficult to understand why this piece of 
work should have been overlooked by the authors 
when it backs up so well their plea for greater 
consideration of the effects of long wavelength 
ultraviolet radiation. 
Yours etc. 
B. E. Johnson, Ph.D. 
Lecturer in Photobiology 
The University of Dundee 
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